The genetic ablation of cPLA2α results in marked suppression of TCDD-induced increase in the expression of COX-2 and mPGES-1 in the kidney and excretion of PGE2, and subsequently in hydronephrosis onset [48]. The gene discussed is PTGS2; the disease is hydronephrosis.